Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study.

Wolfgang M Brueckl* (First author), Martin Reck, Harald Schäfer, Kai Neben, Frank Griesinger, Justyna Rawluk, Stefan Krüger, Konrad Kokowski, Joachim H. Ficker (Co-author), Miriam Möller, Andrea Schueler, Eckart Laack

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)101394
JournalJOURNAL OF GERIATRIC ONCOLOGY
Volume14
Issue number1
DOIs
Publication statusPublished - 2023

Keywords

  • 1ST-LINE TREATMENT
  • ELDERLY-PATIENTS
  • OPEN-LABEL
  • REPORTED OUTCOMES
  • DRUG-INTERACTIONS
  • BRAIN METASTASES
  • PHASE-III
  • ADENOCARCINOMA
  • OSIMERTINIB
  • GEFITINIB

Cite this